Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.49.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.3.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LP.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LQ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MD.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MB.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
unclassifiableNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCENYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GQ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.9.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HD.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HQ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FD.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FT.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used